Substudies Submission
- Information requested for a submission of an I-CARE substudy :
- Substudy Protocol
- Methodologic plan
- Local referent methodologist
- Complete file to be sent by Email to : mcoisnon@getaid.org (in cc : icare@getaid.org)
I-CARE substudy project assessement
Main step
-
Substudy submission
-
Executive Committee assessment
-
Methodology assessment
-
Form with minor/major comments
-
Presentation and SCI COM vote during international congress
Why?
To ensure the high quality of I-CARE substudy projects.
Who and what?
- Executive Committee : L.Peyrin-Biroulet, F. Baert, L. Beaugerie, JF. Rahier
- To evaluate faisability with I-CARE database (with or without supplementary data).
- To check overlap with I-CARE main objectives (independant project or in collaboration with Executive Committee to work in main objectives)
- Methodologic commitee : C. Baumann (I-CARE methodologist), H. Rousseau (I-CARE statistician)
K. Kirchgesner (coding group referent), Executive Committee.- To validate project methodology (endpoint, statistical analysis plan, design)
- To ensure compliance with I-CARE database
Substudies received
SUBSTUDY ASSESSMENT | |||
I-CARE STUDY GROUP | EX COM | METHODOLOGY | SCI COM |
DATA IBD 2020 Scientific officer: Glen Doherty |
Pending | ||
PREGNANCY Scientific officer: Mette Julsgaard |
Pending | ||
PREVALENCE OF COMBO THERAPY WITH IS IN IBD PATIENTS RECEIVING BIOLOGICS
Scientific officer: Uri Kupilov |
On Hold | ||
CARDIO VASCULAR RISK Scientific officer: Eran Zittan |
+ | Comments | + |
OLDCARE Scientific officer: Mathurin Fumery |
On Hold | ||
RESPONSE SHIFT (PRO) Scientific officer: Cedric Baumann |
+ | + | |
SURGERY IN PERIANAL CD Scientific officer: Catherine Reenaers |
+ | + | + |
PRIMARY SCLEROSING CHOLANGITIS IN THE I-CARE COHORT
Scientific officer:
Pauline Rivière |
+ | + | + |
EFFICACY OF A BIOLOGICAL-BASED COMBO THERAPY WITH A BIOLOGICAL MONOTHERAPY IN INDUCING AND MAINTAINING CLINICAL REMISSION
Scientific officer:
Julien Kirchgesner |
On Hold | ||
COVID 19 SUBSTUDY
Scientific officer:
Aurelien Amiot |
+ | + | + |
NON I-CARE INVESTIGATORS (NIIISS) | |||
PREDICTIVE MODEL Scientific officer: Parambir Dulai |
Pending* | ||
SAPHIRE (Pas de Protocol reçu) Scientific officer: Jean-Fred Colombel |
Pending* | ||
VTE RISK Scientific officer: Véronique Regnault |
Pending* | ||
MORTALITY RATES AND CAUSES IN IBD patients (new substudy) Scientific officer: Koldo Garcia Etxebarria |
Pending* |
* To be voted
Red : Overlap width I-CARE main objective